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Bacterial infections are a leading cause of morbidity and mortality worldwide. In spite of great advances in biomaterials research
and development, a significant proportion of medical devices undergo bacterial colonization and become the target of an implant-
related infection.We present a review of the twomajor classes of antibacterial nanostructuredmaterials: polymeric nanocomposites
and surface-engineered materials. The paper describes antibacterial effects due to the induced material properties, along with the
principles of bacterial adhesion and the biofilm formation process. Methods for antimicrobial modifications of polymers using a
nanocomposite approach as well as surfacemodification procedures are surveyed and discussed, followed by a concise examination
of techniques used in estimating bacteria/material interactions. Finally, we present an outline of future sceneries and perspectives
on antibacterial applications of nanostructured materials to resist or counteract implant infections.
1. Introduction
There is an enormous need today for antimicrobial agents or
coatings able to prevent material surfaces from colonization
bymicroorganisms and periprosthetic tissues from infection.
The increasing development of bacterial resistance to the
most powerful antibiotics and the high rate of nosocomial
infections are of great concern [1], since microbial contami-
nation is a serious issue involving multiple spheres, including
the health care and biomedical industries, water purification
systems, and food packaging and storage. By way of exam-
ple, each year about two million people acquire bacterial
infections in American hospitals, with 90 000 yearly deaths
[2]. Another pertinent fact is that almost half the people in
developing countries suffer from water-related diseases, and
more than three million people die annually from illnesses
associated with unsafe drinking water due to the lack of
disinfection.TheEuropeanAntimicrobial Resistance Surveil-
lance System (EARSS) reported the prevalence ofmethicillin-
resistant Staphylococcus aureus (MRSA) in at least 10% of all
S. aureus-associated infections in most European countries,
rising as high as 40% to 50% in some cases, with a signif-
icant increase between 1999 and 2002 in Austria, Belgium,
Germany, and the UK [3].
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Figure 1: Schematic view of the two approaches applied in our laboratory to develop engineered nanostructured polymericmaterials for anti-
bacterial applications.
These alarming numbers underscore the importance of
broad-range antimicrobial agents for infection prophylaxis in
orthopedic trauma surgery. In response, numerous antimi-
crobial agents have been developed that can effectively inhibit
the growth of microorganisms [4]. After the improvements
achieved during the last few decades in terms of aseptic
techniques, control of environment sterility, perioperative
antibiotic prophylaxis, and anti-infective biomaterials have
progressively become a primary strategy to prevent medical
device-associated infections [5, 6]. The characteristics that
antibacterial biomaterials should ideally possess are therefore
diverse, while the required potency and spectrum of activity
must reflect the risk rate and the etiology of infections
under specific circumstances of use [7]. Furthermore, while
antibacterial biomaterials are utilized for the construction of
medical devices to be endowed with anti-infective adjunctive
bioactive properties, ultimately determining their resistance
to infections, they can also be employed to deliver medical
substances, whose primary scope is the prevention, treat-
ment, or reduction of infections, thus further widening the
fields of application [8].
Hence, research concerning the development of antimi-
crobial polymers represents a great challenge for both the aca-
demic world and industry. Antimicrobial polymers can help
to prevent biofilm development and to solve the problems
associated with the use of conventional antimicrobial agents,
such as residual toxicity, short-term antimicrobial activity,
and development of resistant microorganisms.
Nanostructured materials with good antibacterial prop-
erties and biocompatibility/environmental safety have also
been attained [7, 9–11]. Although the design and development
of biomaterials have significantly advanced over the past
decade, great challenges remain for fundamental exploration
and practical applications.
With the advent of nanotechnology, an attempt wasmade
to replace the biocides from antimicrobial paints with various
nanosized substances such as zinc oxide, titanium dioxide,
and silver [9, 12–14]. The application of nanotechnology con-
cepts tomedicine joins two large cross-disciplinary fieldswith
an unprecedented societal and economical potential arising
from the natural combination of specific achievements in
the respective fields. The common basis evolves from the
molecular-scale properties relevant to the two fields. The
application of nanoscaled materials and structures, usually
ranging from 1 to 100 nanometers (nm), is an emerging area of
nanoscience and nanotechnology [15]. Nanomaterials often
show unique and considerably changed physical, chemical,
and biological properties compared to their macroscaled
counterparts. They may provide solutions to technological
and environmental challenges in the areas of solar energy
conversion, catalysis, medicine, and water treatment [9].
Moreover, functional nanocomposites with desired proper-
ties can be tailored by incorporating specific nanomaterials
and/or nanoparticles into the selected polymer matrix [10,
16, 17], while surfaces can be engineered by using different
surface modification methods or coatings [9, 18].
The aim of this paper is to bring attention to the evolu-
tion and potentiality of emergent active nanocomposite and
surfacemodification approaches in antibacterial applications.
Figure 1 shows a schematic view of the two approaches used
to develop engineered nanostructured polymeric materi-
als for antibacterial applications: nanocomposites based on
biodegradable polymers and antimicrobial nanostructures
with potential application in tissue engineering and surface
modifications based on plasma treatment in order to induce
specific surface topography that affects the microbial vitality.
The focus of this review is on the relevant polymeric
nanocomposite materials for antimicrobial applications
(polymers, organic/inorganic nanostructures, and matrices)
and the nanostructure interaction, including strategies for
engineering surface in terms of modifications. Before intro-
ducing the antibacterial, nanostructuredmaterials developed
by using two different nanotechnological approaches, we will
briefly review the mechanism of bacterial adhesion and
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Figure 2: Phase one of bacterial adhesion consists in the initial attraction of the cells to the surface through the effects of physical forces.These
physical interactions are further classified as long-range interactions (nonspecific, distances >50 nm between cells and surfaces) and short-
range interactions (distances <5 nm, with involvement of hydrogen bonding, ionic and dipole interactions, and hydrophobic interactions).
biofilm formation on a surface. Finally, we will conclude by
summarizing the techniques used in estimating bacteria-
material interactions.
2. Bacterial Adhesion and Biofilm Formation
Tens ofmillions ofmedical devices are used each year. In spite
of many advances in biomaterials, a significant proportion of
all device types becomes colonized by bacteria and becomes
the target of an implant-related infection [19]. Infection
remains a major impediment to the long-term use of many
implanted or intravascular devices and it is expected to
further increase due to (i) the improved detection of biofilm-
related infections by replacing diagnosis based on culture
methods (often falsely negative) with reliable molecular tech-
niques [20, 21]; (ii) the growing number of implanted devices
in the aging population; and (iii) the increasing residency
time of implanted devices, which are at continuous risk for
infection during their implanted lifetime. Frequently, failure
of implant devices stems from the bacterial colonization of
polymer surfaces followed by the formation of a thick, multi-
layered biofilm which is extremely resistant to host defense
mechanisms and antibiotic treatment.Often the only solution
to an infected implanted device is its surgical removal.
Adhesion of bacteria to human tissue surfaces and
implanted biomaterial surfaces is an important step in the
pathogenesis of infection, whereby the bacteria can divide
and colonize the surface [22–30]. Bacterial adhesion is an
extremely complicated process that is affected by many
factors, including environmental issues, the associated flow
conditions, the presence of serum proteins or antibiotics,
the bacterial properties, and the material surface character-
istics [23, 31]. Bacterial adhesion to a material surface can
be described as a two-phase process, including an initial,
instantaneous, and reversible physical phase (phase one),
followed by a time-dependent and irreversible molecular and
cellular phase (phase two) [23, 31, 32]. Phase one of the
bacterial adhesion consists in the initial attraction of the cells
to the surface through the effects of physical forces, such as
Brownian motion, van der Waals attraction forces, gravita-
tional forces, the effect of surface electrostatic charge, and
hydrophobic interactions [31–33].These physical interactions
are further classified as long-range interactions (nonspecific,
distances>50 nmbetween cells and surfaces) and short-range
interactions (distances <5 nm, with involvement of hydrogen
bonding, ionic, and dipole interactions and hydrophobic
interactions) (Figure 2). Long and short interactions are fun-
damental for the initial part of bacterial adhesion to surfaces,
which makes the molecular or cellular phase of adhesion
possible [23, 26, 31, 32]. The bacterial properties (bacterial
hydrophobicity and bacterial surface charge) and thematerial
surface characteristics (surface chemical composition, sur-
face roughness, and surface configuration) are important in
bacterial adhesion to uncoated surfaces and can potentially
be targeted in antiadhesion therapy [33–35].
Phase two consists in molecular specific reactions
between bacterial surface structures and substratum surfaces,
uncoated or coated with host matrix proteins (i.e., albumin,
fibronectin, fibrinogen, vitronectin, and laminin). To this
end, the bacterial surface polymeric structures, which include
capsules, fimbriae, or pili and slime, are responsible for
the firm adhesion of bacteria to a surface. Attachment to
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Figure 3: Scanning electron microscopy images of biofilm produced by S. aureus LP [116] and S. epidermidis RP62A [117] in the air liquid
interphase of TSB-glucose medium after 24 h incubation at 37∘C ((a) and (b): magnification, ×5 000).
Surface
(a)
(b) c
(d)
(c)
(e)
(f)
(g)
Extracellular matrix:
• Proteins (e.g., adhesive pili,
anchored or anchorless
staphylococcal proteins)
• Exopolysaccharides
• eDNA
• Enzymes
Figure 4: The different stages of biofilm formation: (a) planktonic cell; (b) reversible attachment to the surface; (c) irreversible attachment
to the uncoated or protein coated surface; (d) formation of microcolonies through cell division and extracellular matrix production;
(e) formation of a mature three-dimensional biofilm architecture showing pores for the passage of water. Cell detachment from the biofilm:
(f) an active process leaving planktonic cell; (g) a passive process that can be shed through mechanical disruption adapted from [36].
materials coated with host matrix or plasma proteins is medi-
ated by microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs) [36, 37].
Beyond phase two, certain bacterial strains are capable of
forming a biofilm (Figure 3) if provided with an appropriate
supply of nutrients. Bacteria frequently involved in biofilm-
associated infections include the Gram-positive pathogens
Staphylococcus epidermidis, Staphylococcus aureus, and Strep-
tococcus species and the Gram-negative Pseudomonas aerugi-
nosa and Enterobacteriaceae such as Escherichia coli [38].
Biofilm formation includes several sequential steps in
which planktonic bacteria initially stick to a solid surface,
which may be either unmodified or coated with host plasma
proteins, followed by cell proliferation, cell-cell interaction,
and production of an extracellular polymeric matrix, where
bacteria accumulate in multilayered clusters (Figure 4). Fol-
lowing initial attachment, bacteria start growth and coloni-
zation, which results in the formation of contiguous cellular
layers. The formation of multicellular clusters is based on
intercellular adhesion and attachment of bacteria to a poly-
meric substrate produced, released, and integrated into the
extracellular matrix. This step includes the contribution of
the exopolysaccharides (e.g., staphylococcal polysaccharide
intercellular adhesin (PIA), P. aeruginosa alginate), proteina-
ceous factors (e.g., adhesive pili, anchored or anchorless
staphylococcal proteins), extracellular DNA (eDNA) [39],
and enzymes. The subsequent development of the mature,
three-dimensional biofilm architecture includes regulated
motility. Once the structure has developed and matured,
some bacteria detach and disperse into the surrounding
medium, enabling the biofilm to spread over the surface [6,
30, 36]. Mature biofilms are highly resistant not only to the
action of the innate and adaptive immune defense systems,
but also to the action of antimicrobial agents and disinfect-
ants. There are several possible mechanisms underlying this
phenotypic resistance, which may depend both on the type
of antibiotic treatment and the microorganism: slow rate
of growth in the biofilm, altered metabolism, titration and
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inactivation of antimicrobial agents by the extracellular
matrix, and the presence of an existing oxygen gradient
that prevents the action of some antibiotics [40–42]. In
addition, biofilms contain a large subpopulation of so-called
persister cells that are constituted of dormant cells surviving
antimicrobial treatment [43] and adapting to a slow growth
rate through the emergence of small colony variants [41].
A limited diffusion of antimicrobials into biofilms has been
suggested, but in most instances, no direct evidence has been
provided [44, 45].
Biomaterial-associated infections have an enormous
impact in terms of morbidity of the patients and costs to
national health systems. In recent years, there has been
increasing interest in anti-infective biomaterials aimed at
counteracting the worrisome phenomenon of biomaterial-
associated infections [46]. The creation of new anti-infective
biomaterials can be obtained by alternative approaches ori-
ented in different directions to promote a reduction in
infection.
3. Polymeric Nanocomposite Approach to
Provide an Antimicrobial Response
Polymer nanocomposites have attracted considerable atten-
tion in recent years and have become keymaterials inmodern
nanotechnologies [10, 17].This interest arises because of their
unprecedented performance, improved properties compared
to the constituent parts, design flexibility, lower life-cycle
costs, and uniquely large applicability of nanocomposites in
various industrial fields. They consist of organic/inorganic
nanoparticles incorporated in polymers that allow newmate-
rials to be obtained withmodulated and distinct optical, elec-
trical, and catalytic properties. These have potential applica-
tions in catalysis, bioengineering, photonics, and electronics
[10, 17, 47].
In order to obtain an antibacterial polymeric nanocom-
posite, antimicrobial nanoparticles have to be selected and
incorporated into the polymermatrices by conventional tech-
niques (extrusion, injectionmolding, blowmolding, etc.) [10,
17, 48–50]. Polymers are considered a good host material for
metal nanoparticles; both biodegradable and nonbiodegrad-
able polymer matrices are currently used in designing new
nanocomposite systems with antimicrobial properties [10,
51].
Nanoparticles of noble metals have been studied with
growing interest, since they exhibit markedly distinct phys-
ical, chemical, and biological properties from their bulk
counterparts and there is a very strong interest in the use of
metal and semiconductor clusters as advanced additives for
plastics with considerable research done in this novel field of
composite science. The metal and metal oxide nanomaterials
commonly used as antimicrobial agents are silver (Ag), gold
(Au), zinc oxide (ZnO), silica (SiO
2
), titanium dioxide
(TiO
2
), alumina (Al
2
O
3
), and iron oxides (Fe
3
O
4
, Fe
2
O
3
)
[7, 50–52]. Antimicrobial polymer additives are now available
commercially.They are designed for various types of polymer
matrices and processing techniques.These additives are often
based on organic compounds or some metals [14, 51, 53–55].
However, it should be noted that only a marginal number of
them are considered for medical use [56].
The chemical nature of the nanoparticles, their capping
agent, and even the medium in which they are prepared
might play an important role in determining the interaction
between the polymer matrix and the nanofiller, thus affecting
the dispersion and the bulk behavior of the nanocomposite
films [57, 58]. Various methods to develop polymer nano-
composites by using metal nanoparticles have been devel-
oped, but sustained efforts need to be directed toward con-
trollability for nanoparticle size, shape, distribution, and its
interaction with polymers. Exploration of an inexpensive,
easy fabricationmethod to fabricate polymeric nanocompos-
ites with well-tuned nanoparticle size, shape, distribution,
and interaction with polymers will be very important for var-
ious practical applications. Different chemical and physical
methods exist to prepare metal polymer composites [54].
TiO
2
-chitosan nanocomposite is an optimalmaterial pos-
sessing high potential for bone reconstruction, regeneration,
and tissue engineering, based on its biomimic, bioactive, and
biocompatible nature [48]. The smaller particle size of TiO
2
-
chitosan increases the absorption of nutrients from the body
and helps the formation of an apatite layer through the con-
ventional principles of surface/volume ratio. Recently, TiO
2
-
chitosan nanocomposites, synthetized with five different
chitosan ratios, have proved to be promising biomaterials for
orthopedic and tissue engineering applications. High surface
area, appropriate hydroxyapatite formation, specific antibac-
terial action, increased cell viability, controlled swelling, and
degrading rate are the favorably achieved features of the
composite at a 2 : 1 titanium : chitosan ratio [48].
Another emerging class of nanoantimicrobials is bioac-
tive copper (Cu) nanomaterials, which provide complemen-
tary effects and characteristics compared to other nanosized
metals, such as silver or zinc oxide nanoparticles. It is known
that copper is a broad-spectrumbiocide and effectively inhib-
its the growth of bacteria, fungi, and algae. Recent studies
have reported that nanoscale Cu exhibits good antibacterial
activity [14, 59], and the products withCu containing surfaces
may meet hospital requirements [53]. Unlike silver (Ag),
which has been studied extensively for antibacterial applica-
tions, Cu is an essential element for living organisms, and it
might even be suitable for biomedical applications.Moreover,
Cu is currently cheaper than Ag in the market and there-
fore, a method utilizing Cu would prove to be quite cost
effective. The general mechanism of the antibacterial activ-
ity of nanoscale, metal-based materials is still uncertain.
The antimicrobial activity of copper-based nanostructures
depends on the microbial species and on the experimental
setup.
Cu nanoparticle-coated cellulose films were developed
through one-step reduction with antibacterial properties by
[51]. The nanocomposite film exhibited strong, efficient anti-
bacterial activity against S. aureus and E. coli.All the bacteria
were killed within 1 h, and the dramatic reduction of viable
bacteria could be observed within 0.5 h. The rapid killing
effect was not only due to the release of Cu ions, but also due
to contact killing. These characteristics increase the scope of
applications of Cu/cellulose nanocomposite film in biomedi-
cal, catalysis, packaging, and electronics applications [51].
In the area of bioscience it was shown that square-
patterned ZnO nanostructures integrated into biosensor
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Figure 5: Atomic force microscopy (AFM) (a) and field emission scanning electron microscopy (FESEM) (b) images of PLGA/3Ag nano-
composite surfaces.
arrays may allow ultrasensitive protein fluorescence detec-
tion, owing to the fluorescence-enhancement capability of
nanoscale ZnO [60].
As an antibacterial agent, ZnO has several advantages:
noticeable activity in the pH neutral region (pH = 7-8) with-
out the presence of light [13]. ZnO nanoparticles were pre-
pared within an alginate biopolymer by microwave (MW)
treatment. The nanoparticles that were obtained were mostly
spherical in shape and had a hexagonal crystal structure. The
onset of the absorption of the ZnO-alginate nanocomposite
solutions was shifted towards a lower wavelength due to
the nanosized dimensions of the particles. A band-to-band
recombination dominates the photoluminescence spectra of
all the samples, while the intensity of the peaks that originate
from the defects on the nanoparticle surfaces increases with
the time of MW treatment. Antibacterial activity tests were
carried out with S. aureus and E. coli pathogens. All the ZnO-
alginate nanocomposite samples showed fast, strong antibac-
terial activity, with 99.9% reduction for S. aureus and 100%
reduction for E. coli after 2 h of exposure [49].
Nanosilver is regarded as a new generation of antibacte-
rial agents and the unique properties of silver nanoparticles
(Ag NPs) have been extended into a broader range of appli-
cations. Incorporation of Ag NPs with other materials is an
attractive method of increasing compatibility for specific
applications [50]. Multifunctional nanocomposites based on
biodegradable polymer matrix and silver nanoparticles have
attracted great interest in nanobiotechnology due to the anti-
microbial properties of silver, which are retained during poly-
mer degradation [61, 62]. Silver species can be released in a
controlledmanner [63] and, for this reason, silver-containing
materials have been extensively used to prevent the attack of
a broad spectrum of microorganisms in different fields of
application.
Dural Erem et al. [64] developed a series of PLA nano-
composite fibers containing, respectively, 0 wt%, 0.5 wt%,
1 wt%, 3wt%, or 5wt% Ag NPs, which exhibited increased
antimicrobial activity, depending on the filler content. On the
other hand, mechanical and thermal characterization tests,
including thermogravimetric analysis, differential scanning
calorimetry, and tensile testing, showed that increasing con-
centrations of silver hindered the mechanical properties of
nanocomposites due to partial agglomeration, leading to the
generation of flaws [64].
Our group previously reported the development of dif-
ferent Ag NP-based nanocomposites by using biodegradable
polymers, in the formof poly(lactic acid) (PLA), poly(glycolic
acid) (PGA) [11, 50, 57, 58, 65, 66], and poly(vinyl alcohol)
(PVA) [16], and by means of different production processes,
to be used in both biomedical and packaging applications.
Nanocomposite films based on a biodegradable poly(DL-lac-
tide-co-glycolide) copolymer (PLGA) and different kinds and
concentrations of silver nanoparticles were developed by sol-
vent casting. We demonstrated that PLGA film morphology
can be modified by introducing a small percentage of silver
nanoparticles that do not affect the degradation mechanism
of the PLGA polymer in the nanocomposite. Figure 5 shows
atomic force microscopy (AFM) (a) and field emission
scanning electron microscopy (FESEM) images of PLGA/Ag
nanocomposite surface with 3 wt% of silver nanoparticles,
developed by solvent casting process. Images underline the
specific surface topography with the presence of a superficial,
circular porous structure with a pore diameter of about
10 𝜇m. Results clearly evince the stabilizing effect of the Ag
nanoparticles in the PLGA polymer and the mineralization
process induced by the combined effect of silver and nano-
composite surface topography. The silver ion release can be
controlled by the polymer degradation processes, showing
a prolonged antibacterial effect [57, 58, 62, 65]. Results of
the research suggest that the combination of biodegradable
polymers and silver nanoparticles opens a new perspective
for the use of nanomaterials with tunable properties in
producing antimicrobial surfaces for biomedical applications.
The antibacterial action of silver for biomedical devices
has been the subject of numerous studies and, while opinions
differ, the most probable scenario seems to be that silver
ions bind to the bacterial cell membrane and damage it by
interfering with membrane receptors and with bacterial elec-
tron transport. For this reason, we recently investigated the
possibility of using a poly(𝜀-caprolactone) (PCL) biodegrad-
able matrix reinforced with single-walled carbon nanotubes
(SWCNTs) and silver nanoparticles as a potential support
for primary human bone marrow-mesenchymal stem cells
(hBM-MSCs) [67].The newly designed SWCNT- andAgNP-
based materials possessed the unique properties offered by
the synergistic interaction of the two different reinforcement
phases. Figure 6 illustrates transmission electron microscopy
(TEM) images of the ternary nanocomposite, showing
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Figure 6: Transmission electron microscopy (TEM) image of
poly(𝜀-caprolactone) (PCL) ternary nanocomposite based on SWC-
NTs and Ag NPs.
the interaction and themorphology of the twodifferent nano-
structures [65].The suitability of these conductive nanocom-
posite films as support for hBM-MSC cells was demonstrated,
showing comparable viability and cell/material interaction
during the culture period. Moreover, it was proved that there
is a clear concentration difference between the antimicrobial
effects of nanosilver and potential adverse human cell or
tissue reactions that encourage the application of the Ag NPs
as conductive antimicrobial nanostructures able to induce
stem cell activation.
The factors influencing bacterial adhesion to a bioma-
terial surface and, thus, the antimicrobial response include
chemical composition [68], surface charge, hydrophobicity,
and, in particular, surface roughness, topography, or physical
configuration [26].The electrospinning technique has proven
to be a valuable method for developing antimicrobial PLGA
nanocomposites based on Ag NPs [69]. Nirmala et al.
reported on the electrospinning fabrication of cheap, stable,
effective nanofiber mats with excellent antimicrobial activity,
based on polyurethane (PU) nanofibers containing silver
nanoparticles, that can be utilized to inhibit the microbial
growth associated with food stuffs [70].
Recently in our laboratory we investigated the proper-
ties (mechanical, antibacterial, and degradation under com-
posting conditions) of poly(lactic acid) and its composites
prepared with a combination of microcrystalline cellulose
(MCC) and silver nanoparticles, in order to show the pro-
spective approach offered by these new multifunctional sys-
tems [66]. We demonstrated that the synergic effect of silver
nanoparticles and cellulose structures increases the thermal
and mechanical responses of PLA matrix. A bactericidal
effect of Ag NP-based binary and ternary PLA nanocom-
posites on S. aureus and E. coli was detected at all time
points and temperatures analyzed.The selected content of Ag
NPs (1 wt%) in the nanocomposite formulations produced an
evident antimicrobial effect and provided an active system
for food packaging applications. Moreover, the low silver
quantities do not influence the organic biowaste maturation
process during the test for disintegrability under composting
conditions. We have also found that the antibacterial activity
of the PLA nanocomposites containing Ag NPs was greater
on E. coli than on S. aureus cells, confirming previous work
that explained that Ag nanoparticles appear more toxic to E.
coli than to S. aureus [71].
In a recent study, melt-compounding extrusion followed
by a film forming process was explored as a technique
for preparing cellulose nanocrystal-based nanocomposites.
High performance nanocomposites for packaging applica-
tions were produced by combining nanocrystalline cellulose
(CNC) and silver nanoparticles with PLA polymer matrix;
the antibacterial activity of these ternary systems against S.
aureus andE. coli cells was studied [50]. For S. aureus, the bac-
terial activity was still remarkable in the presence of ternary
systems, while the antibacterial effect of the nanocomposites
was evident against the E. coli cells.The reduced antibacterial
activity on S. aureus may be due to its structural character.
Gram-positive and Gram-negative cells differ markedly in
their cell walls.The thicker cell wall of S. aureus is of immense
practical importance in protecting the cell from penetration
of silver ions into the cytoplasm. The results of the study
suggested that the better dispersion of Ag nanoparticles, con-
firmed by morphological, thermal, and mechanical analyses,
positively affected the interaction of silver ions with the
bacteria and this mechanism was found to be greater for S.
aureus cells than for E. coli. This is due to different bacterial
properties, suggesting perspectives for food packaging and
hygiene applications that require an antibacterial effect that
is constant over time.
4. Surface Engineering as a Strategy to
Modulate Antimicrobial Response
The surface properties of biomaterials determine the kind
and strength of communications between the biological envi-
ronment and the materials. Recently D’Angelo et al. demon-
strated that surface topography was able to induce stem cell
differentiation as a single cue [72]. The factors influencing
bacterial adherence to a biomaterial surface include chemical
compositions [73, 74] surface charge [75], hydrophobicity
[76], and surface roughness or physical configuration [77].
Depending on the hydrophobicity of both bacteria andmate-
rial surfaces, bacteria differently adhere to substrates with
modified superficial properties [78]. McAllister et al. found
that the irregularities of polymeric surfaces promote bacterial
adhesion [79, 80].
Modifying the surface characteristics of the biomaterial
without altering the structural properties is, therefore, a
strategy that has been used in recent years to obtain antibac-
terial materials [81]. The first essential step is the controlled
fabrication of model surfaces.
This approach originates from the basic assumption that
modifying the surface properties of a material (surface free
energy, polarity, and topography) may result in diminishing
bacterial adhesion during the initial stage of the biofilm
formation process. For these reasons, many approaches to
modify the surface of biodegradable polymer supports have
been undertaken in order to introduce useful surface charac-
teristics to the polymer. These can be mainly divided into (i)
surface modification and (ii) surface deposition.
Surface modification can be performed either by apply-
ing wet chemistry through reaction with various chemical
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reagents or by applying high-energy electromagnetic radia-
tion (e.g., by laser, ultraviolet radiation, and gamma rays).
The interaction of a polymeric surface with electromagnetic
radiation causes surface activation (through the breakage of
accessible polymer bonds), permitting subsequent chemical
modification [82–84]. Another promising method is mod-
ifying polymer surfaces by ionized gas (plasma). By using
plasma processes, it is possible to change the surface chem-
ical composition and properties such as wettability, surface
energy, refractive index, hardness, chemical inertness, and
biocompatibility [85]. This leads, naturally, to the selection
of so-called cold plasma when the temperature of the treated
material does not reach high values in comparison with the
ambient temperature. This method demands low pressure
(0.1–100 Pa) and the presence of a working gas (usually N
2
,
O
2
, or Ar, CF
4
). Wan et al. demonstrated that appropriate
oxygen plasma treatment could not only incorporate –C–
O– groups onto the PLGA surface and increase its negative
charges, but also produce peaks and valleys on its surface
through an etching effect, thereby changing the surface topo-
graphy [85].
Since surface chemistry and surface topography are both
important factors in influencing biological activity, we
recently analyzed the combined outcomes of silver nanoparti-
cles and radiofrequency plasma surface treatment on PLGA/
Ag nanocomposite [11]. The study demonstrated that oxygen
plasma surface treatment combined with a nanocomposite
approach can readily reduce bacterial adhesion and growth
on silver nanoparticles and PLGA systems. It must be noted
that this reduction was shown for both types of tested bacte-
rial strains (E. coli and S. aureus). The multistep approach we
adopted showed itself to be a promising strategy to modulate
the topographical and physicochemical surface properties
of nanocomposite and, consequently, to regulate the antiad-
herence properties of biodegradable, PLGA-based systems
by curbing the adhesion and growth of the two categories
of tested bacteria [11]. Figure 7 shows a FESEM image of
the oxygen plasma-treated PLGA/3Ag nanocomposite film
developed by the solvent-casting method. The image shows
the plasma effect that was aimed at changing the shape
and depth of the initial pores and at inducing increased
surface roughness, also demonstrating the etching effect of
the oxygen plasma on the PLGA polymer. However, the
plasma modifications to polymer surfaces are characterized
by their weak stability over time, as polymer surfaces tend to
return to their original chemical state [18, 86–92]. Another
disadvantage lies in the complexity of the surface modifica-
tion methods [11, 58].
An alternative strategy to prevent infection is by devel-
oping an antibacterial coating on the surface of the devices.
Moreover, the application of silver nanoparticles on the
surface of medical devices has been used to prevent bacterial
adhesion and subsequent biofilm formation. The nanopar-
ticles are either deposited directly on the device surface or
applied in a polymeric surface coating.
Ho et al. reported the development of a long-term,
active antimicrobial coating for surgical sutures. To this end,
two water-insoluble polymeric nanocontainers based on
hyperbranched polylysine (HPL), hydrophobically modified
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Figure 7: Field emission scanning electron microscopy image of
the PLGA/3Ag nanocomposite film, modified by plasma oxygen
treatment.
by using either glycidylhexadecyl ether or a mixture of
stearoyl/palmitoyl chloride, were synthesized. Highly stabi-
lized silver nanoparticles (Ag NPs, 2–5 nm in size) were
generated by dissolving silver nitrate in the modified HPL
solutions in toluene followed by reduction with L-ascorbic
acid. Poly(glycolic acid)-based surgical sutures were dip-
coated with the two different polymeric silver nanocompos-
ites. The coated sutures showed high efficacies of more than
99.5% reduction of adhesion of living S. aureus cells onto the
surface compared to the uncoated specimen. Silver release
experiments were performed on the HPL-Ag NP modified
sutures by washing them in phosphate buffered saline for a
period of 30 days.These coatings showed a constant release of
silver ions over more than 30 days. After this period of wash-
ing, the sutures retained their high efficacies against bacterial
adhesion. Cytotoxicity tests using L929mouse fibroblast cells
showed that the materials are basically noncytotoxic [93].
Antimicrobial coatings have also been applied to venous
catheters. Coatings containing combinations of antibiotics
and antiseptics like minocycline and rifampin or chlorhexi-
dine and silver-sulfadiazine have been applied to the internal
and external surface of catheters. In several studies these
antimicrobial-coated catheters were compared to noncoated
catheters, and a reduction of catheter colonization and cath-
eter-related bloodstream infections was found [94–96]. The
antimicrobial effect of antibiotic-containing coatings was
more pronounced than for the antiseptic coatings. Halton
and Graves analyzed studies concerning economic aspects of
catheter-related bloodstream infections and concluded that
the use of antibiotic-coated catheters was clinically effective
and cost-saving when compared to antiseptic-coated or
standard catheters [97, 98].
5. Techniques Used in Estimating
Bacteria/Material Interactions
In addition to the different types of nanostructured biomate-
rials that have been synthesized and developed, several exper-
imental techniques have been developed to study and quan-
tify bacterial adhesion and antibacterial activity on material
surfaces [31, 32, 99–102].
Regarding bacterial adhesion techniques, the common
element in all of them is that they measure in vitro the prob-
ability, force, or energy of attachment/detachment of many
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or single bacterial cells. Nevertheless, we need to point out
that the in vivo adhesion process is complex and dynamic
and these measurements might be misleading. These consid-
erations may also apply to the in vitro determination of the
antibacterial activity of biomaterials.
Regarding biofilm assessment, it is important to men-
tion that several conditions during the biofilm formation
process can affect the results, including growth conditions,
the cultivation medium, and the surface selection. The exact
size of the inoculums should be determined quite precisely
by adjusting to a specific optical density or absorbance. Fur-
thermore, the selection of medium composition for biofilm
cultivation is crucial [103]. After the biofilm incubation step,
other parameters need to be taken into consideration for
biofilm quantification such as (i) the bacterial removal and
rinsing procedures (3 washing steps with PBS); (ii) the mea-
surement of planktonic growth before washing (normalizing
biofilms formation by the growth index); (iii) the selection
of the method for the target of quantification; and (iv) the
interpretation of results and evaluation of assay quality [32,
102, 103].
Here, we summarize the in vitro techniques used in
estimating bacteria-material interactions in static conditions:
(a) bacterial/material adhesion and (b) antibacterial activity
of materials.
5.1. Techniques Used in Determining Bacteria-Material Adhe-
sion. To estimate bacterial adhesion, a previously prepared
material surface is overlaid with a suspension of cells for
a determined period and temperature of incubation. The
size of inoculums/surface area, the time (1, 3 or 24 h), and
temperature (4∘, 22∘ or 37∘C) of incubation may be very
important parameters for bacterial adhesion quantification.
Afterwards, the nonadherent cells are removed by rinsing
or centrifugation and the remaining (adhered) cells on the
surface are counted. When centrifugation is used to detach
the nonadherent or weakly adherent bacteria, an overall
estimation of the strength of adhesionmay be calculated.The
remaining (adhered) bacteria and biofilm can be examined
by a number of methods [31, 32, 99, 100] (see (Table 1).
(1) Viable bacterial counting methods include CFU plate
counting, radiolabeling, 5-cyano-2,3-ditolyl tetrazo-
lium chloride (CTC) staining, resazurin assay, and
fluorescein diacetate (FDA) assay [32].
(i) CFU plate counting is the most basic method
for bacterial count. This technique is time con-
suming and involves tediouswork using indirect
and complicated procedures that give more
uncertainty. Its great advantage lies in detecting
only viable bacteria.
(ii) Radiolabeling is useful in the study of bacterial
adhesion to irregular material surfaces. It is
very sensitive and very accurate, allowing for
rapid processing of a large number of samples.
It requires special laboratory space and specific
training for handling radioactivematerials. Fur-
thermore, a potential risk to researchers using
radiolabeling techniques cannot be underesti-
mated.
(iii) CTC is a tetrazolium salt and is reduced by this
respiratory activity to form fluorescent CTC
formazan on the cell surface. Therefore, CTC is
used for specific staining of aerobic live bacte-
ria and can be applied to hard-to-culture bac-
teria. However, since CTC alone is not sensi-
tive enough to stain single cells, an enhancing
reagent that improves the CTC staining effi-
ciency has been added to commercially available
kit.
(iv) Resazurin assay: resazurin, themain component
of Alamar Blue, is a blue redox indicator that can
be reduced by viable bacteria to pink resorufin;
the extent of conversion from blue to pink is a
reflection of cell viability. A calibration curve is
necessary for data quantification.
(v) FDA assay is based on the capability of viable
microbial cells to convert noncolored, nonfluo-
rescent, fluorescein diacetate (FDA) into yellow,
highly fluorescent fluorescein by nonspecific
intra- and extracellular esterases. A calibration
curve is necessary for data quantification.
(2) Microscopy for counting andmorphological observa-
tion of adherent bacteria includes light microscopy,
image-analyzed epifluorescence microscopy, scan-
ning electronmicroscopy (SEM), confocal laser scan-
ning microscopy (CLSM), atomic force microscopy
(AFM), and Fourier transform infrared spectroscopy
(FTIR) [32].
(i) Light microscopy is a technique for bacterial
counting and observation. Normally bacteria
are stained with dyes like crystal violet or
fuchsin. The advances in image analysis make
bacterial counting by light microscopy much
faster and more efficient. In this case, the sub-
strata surfaces have to be translucent to be able
to use light microscopy.
(ii) Image-analyzed epifluorescence microscopy allows
live and dead bacterial cells on the surface to be
distinguished if certain fluorochromes are used.
Cell counting can be performed on an opaque
surface. However, only two-dimensional imag-
ing is possible and the use of fluorochromes is
necessary for viewing bacteria. Furthermore, it
is limited to macroscopic investigation of bac-
teria/surface interactions.
(iii) SEM is a well-established basic technique to
observe the morphology of bacteria adhering
to a material surface, the material surface mor-
phology, and the relationships between the two.
Environmental SEM and low vacuum SEM do
not require metal or carbon sputtering and are
less prone to damaging the bacteria adhering
to a surface or to altering the surface charac-
teristics of the specimen, thereby overcoming
the previously mentioned drawbacks. However,
SEM has some limitations: the enumeration of
10 The Scientific World Journal
Ta
bl
e
1:
Te
ch
ni
qu
es
us
ed
in
de
te
rm
in
in
g
ba
ct
er
ia
-m
at
er
ia
la
dh
es
io
n.
Vi
ab
le
ba
ct
er
ia
co
un
tin
g
m
et
ho
ds
M
ic
ro
sc
op
yf
or
co
un
tin
g
an
d
m
or
ph
ol
og
ic
al
ob
se
rv
at
io
n
O
th
er
di
re
ct
an
d
in
di
re
ct
m
et
ho
ds
M
ol
ec
ul
ar
bi
ol
og
ic
al
te
ch
ni
qu
es
D
et
er
m
in
at
io
n
of
ba
ct
er
ia
l
su
rf
ac
ec
ha
ra
ct
er
ist
ic
s
M
et
ho
ds
of
ev
al
ua
tin
g
bi
ofi
lm
s
(i)
CF
U
pl
at
ec
ou
nt
in
g
(ii
)R
ad
io
la
be
lli
ng
(ii
i)
CT
C
sta
in
in
g
(iv
)R
es
az
ur
in
as
sa
y
(v
)F
D
A
as
sa
y
(i)
Li
gh
tm
ic
ro
sc
op
y
(ii
)I
m
ag
e-
an
al
yz
ed
ep
ifl
uo
re
sc
en
ce
(ii
i)
SE
M
(iv
)C
LS
M
(v
)A
FM
(v
i)
FT
IR
(i)
Sp
ec
tro
ph
ot
om
et
ry
(ii
)C
ou
lte
rc
ou
nt
(ii
i)
Bi
oc
he
m
ic
al
m
ar
ke
rs
C
on
ta
ct
an
gl
em
ea
su
re
m
en
ts
M
or
ph
ol
og
y:
(i)
Im
ag
e-
an
al
yz
ed
ep
ifl
uo
re
sc
en
ce
(ii
)S
EM
(ii
i)
CL
SM
(iv
)A
FM
Bi
ofi
lm
co
nt
en
t:
(i)
Cr
ys
ta
lv
io
le
ta
ss
ay
(ii
)S
yt
o
9
(ii
i)
Re
sa
zu
rin
(iv
)F
D
A
as
sa
y
The Scientific World Journal 11
adhered bacteria is not feasible because of the
small field and time-consuming work; it needs
sample preparation for observation (tedious and
labor-intensive) and the drying step is consid-
ered to cause noticeable cell shrinkage and other
undesirable outcomes, like damage and distor-
tion of the cell; it requires the specimen to be
metal-sputtered; it cannot discriminate between
live and dead bacterial cells; it also requires
specialist equipment and specific training.
(iv) CLSM is a three-dimensional technique using
fluorescentmolecular probes and laser beams to
study in situ bacterial associationswith surfaces.
It can be used to visualize and count bacterial
cells directly on transparent or opaque surfaces.
It allows the examination of the physiological
state (live versus dead) of the adherent bacterial
cells. This technique offers several advantages,
including the ability to control depth of field,
elimination, or reduction of background infor-
mation away from the focal plane, and the capa-
bility to collect serial optical sections from thick
specimens. The main disadvantages are the use
of fluorescent probes to visualize bacteria and
the high cost required for image quality.
(v) AFM has been proved to be useful in imaging
the morphology of individual microbial cells
on solid surfaces, both in dried and hydrated
states. It can be used for mapping interaction
forces at microbial surfaces. AFM is a noninva-
sive microscopic technique capable of imaging
surfaces at nanometer resolutions and three-
dimensional images at high resolution. Fur-
thermore, no sample staining, dehydration, or
metallic coatings are necessary for this method.
AFM image resolution is higher than that of
environmental SEM. Nevertheless, there are
some disadvantages such as the limitation of
the observation area if compared with SEM and
the unfeasibility of discriminating between live
and dead bacterial cells. Furthermore, imaging
bacterial cells can be a time-consuming task.
(vi) FTIR measures the vibrations of chemical
bonds within all the biochemical constituents of
cells (i.e., proteins, lipids, polysaccharides, and
nucleic acids) and thus provides quantitative
and qualitative information about the total
biochemical composition of the intact whole
microbial cell. The FTIR method is rapid, non-
invasive, accurate, automated, inexpensive, and
quantitative, allowing users to collect full spec-
tra in a few seconds per sample.
(3) Other direct and indirect methods include spectro-
photometry, Coulter count, and biochemical markers
(ATP) [32].
(i) Spectrophotometry is a method measuring how
much a chemical substance (i.e., bacterial cells)
absorbs light as it passes through a sample.
Unfortunately, it cannot discriminate between
live and dead bacterial cells.
(ii) The Coulter principle is a versatile, robust, and
accurate nonoptical method for counting and
sizing particles of all types, including bacterial
cells.
(iii) ATP is present in all cells and its determination
is considered a valid biochemical marker of cell
viability.
(4) Molecular biological techniques: these techniques can
be used to identify the total community of bacteria
attached to a surface. They offer a very sensitive
method for detection of specific genes or species by
using polymerase chain reaction (PCR) and quanti-
tative PCR (qPCR). One of the major limitations is
related to the use of specific oligonucleotide probes
that must bind specifically to the bacterial DNA
sequence [32].
(5) Determination of bacterial surface characteristics
includes contact angle measurements. In the contact
angle technique, a water droplet is applied to the
surface of a dried lawn of bacteria. The angle formed
where the water contacts the organisms is propor-
tional to the surface hydrophobicity of the bacteria.
Even if the analysis is very quick to perform, the
contamination of test surface may alter the values
obtained [32].
(6) Methods for evaluating biofilm include biofilm recog-
nition, thickness, and density measurements, and
morphological observations can be performed by
image-analyzed epifluorescence microscopy, SEM,
CLSM, and AFM as previously indicated. Measure-
ment of biofilm content can be determined by col-
orimetric biomass assay (crystal violet), Syto 9 assay
(also used in CLSM studies of biofilm composition
and morphology), resazurin assay, and FDA assay
[32].
(i) Colorimetric biomass assay (crystal violet): crys-
tal violet (CV) is a basic dye that stains both
living and dead cells, by linking to negatively
charged surface molecules and polysaccharides
in the extracellular matrix. CV assay is econom-
ical and straightforward for all microorganisms.
It cannot be used for cell viability because it
cannot discriminate between live and dead cells.
(ii) Syto 9 assay: the fluorogenic dye Syto 9 is a
nucleic acid stain, which diffuses passively
through cellular membranes and binds to DNA
of both viable and dead cells. As DNA is also
a substantial part of the extracellular matrix,
this staining will provide information on total
biofilm biomass. Some limitations include no
discrimination between live and dead cells; Syto
9, being a reagent, is quite expensive.
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5.2. Techniques Used to Asses Antibacterial Material Proper-
ties. In recent years, nanostructured materials have attracted
broad attention because of their novel physical, chemical,
and biological properties as well as their potential use in
many applications [9, 102, 103], especially those of metallic
nanoparticles and their corresponding metal oxides, such as
copper [14, 91, 104, 105], silver, [52, 62, 64, 93], zinc oxide,
[13, 106], and titaniumoxide [101, 107–109].The antimicrobial
activity of nanoparticles (NPs) has largely been studied with
human pathogenic bacteria such as Escherichia coli [12, 105]
and Staphylococcus aureus [12, 104]. The functional activities
of NPs are influenced largely by the particle size, stability, and
concentrations. NPs have been incorporated into polymeric
nanocomposites using stabilizers or additives which allow
them to be better distributed.
The strategy for testing the performance of anti-infective
bioactive materials in vitro has to correspond to the char-
acteristics of the test materials and their expected effects
and mechanisms of action. Polycationic coatings or surfaces
with immobilized antimicrobial substances that kill bacteria
on contact should follow a different scheme of testing than
disinfectant or antibiotic-releasing biomaterials. The same
applies to the special case of biomaterial surfaces that act
on bacterial physiology and biofilm structural integrity [102].
To estimate antibacterial material properties, a previously
prepared material surface is overlaid with a suspension of
cells for a determined period of time and temperature of
incubation. The size of inoculums/surface area to test, the
time (1, 3, and 24 h or more), and the temperature (4∘C, 22∘C,
or 37∘C) of incubation can be very important parameters
for antibacterial activity quantification and are related to the
material target application. It is important to note that, for
the time-kill tests, a material can be defined as bactericidal
only when abating the concentration of viable bacteria by at
least 3 logs (99.9% when expressed in terms of percentage)
[110, 111], while effects of lower order are not considered to be
(clinically) significant. At the end of incubation, the bacterial
suspension is removed from the surface and cell viability
immediately examined by a number of different methods
[102] (Table 2), as described below.
(1) Evaluation of bacterial survivability: CFU plate
counting, CTC staining, resazurin assay, and FDA
assay. These methods are identical to the previously
reported for bacterial adhesion quantification and can
be used to evaluate bacterial cell survivability of the
initial applied inoculum. The results must be com-
pared with the material surface without the antibac-
terial substances or NPs.
(2) Determination of antibacterial activity by agar well or
paper disk diffusion method [112].
(3) Determination of intercellular component leakage
(cations, RNA, DNA, and protein): the leakage of
intercellular components can be an indirect method
for assessing bacterial membrane damage.
(4) Microscopy for morphological observation: trans-
mission electron microscopy (TEM), SEM, and AFM
are used to show membrane damage and progres-
sive destructions of cells directly in contact or after
interaction with an antibacterial surface. Confocal
laser scanning microscopy (CLSM) can be effectively
performed to show cell membrane damage using the
LIVE-DEAD BacLight bacterial viability kit. The kit
includes two fluorescent nucleic acid stains: Syto 9,
which penetrates both viable and nonviable bacteria
and propidium iodide, which penetrates bacteria with
damaged membranes and quenches Syto 9 fluores-
cence. Dead cells, which take up propidium iodide,
fluoresce red, while cells fluorescing green are deemed
viable.
(5) Determination of lipid peroxidation products by
spectroscopic studies: this type of determination has
been reported especially with TiO
2
surfaces. X-
ray diffraction [113], laser kinetic spectroscopy, and
attenuated total reflection Fourier transform infrared
spectroscopy (FTIR) [114–117] have been used to show
cell disruption due to lipid peroxidation or direct
oxidation.
(6) Evaluation of bacterial cell killing inside the biofilm
is carried out by image-analyzed epifluorescence
microscopy, SEM, CLSM, and AFM as well as col-
orimetric biomass assay (crystal violet), Syto 9 assay,
resazurin assay, and FDA assay.
6. Conclusions and Future Research
Better understanding of the interaction between microor-
ganisms, the implant, and the host may improve our cur-
rent approach to the diagnosis and treatment of implant-
associated infections [118–122]. Despite multiple efforts to
discover medical therapies for treating biofilm infections,
the physical removal of an infected medical device is often
necessary, thus carrying an additional economic cost. There
is consequently great interest in findingmethods or strategies
to inhibit biofilm formation [21]. Combined use of multiple
antimicrobial agents with different chemistries and modes of
action may be a strategy to improve the performance of these
antimicrobial agents and circumvent bacterial adaptation
[123]. However, the tremendous resistance of biofilms to
conventional antibiotic therapy—together with the risk of a
biofilm production induced by antibiotics themselves [124]—
has prompted a great deal of research on synthetic surfaces
and coatings that resist bacterial colonization. Several bio-
materials used in orthopedic surgery demonstrate varying
susceptibilities to infection because adhesion and growth
of infecting bacteria are controlled by biomaterial surface
properties like hydrophobicity [125] and roughness [125,
126]. Controlling the topography and hydrophobic properties
of materials surfaces is thus a way to influence bacterial
interaction with the surface and must be taken into account
when developing novel, anti-infective biomaterials [127, 128].
However, since bacterial adhesion is a very complex pro-
cess affected by many factors, such as bacterial and material
properties and environment, further studies are required
to understand the mechanisms of bacterial adhesion and
implant infection and to provide adequate methodologies to
prevent them from occurring. Future research must strive to
The Scientific World Journal 13
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better understand the pathogenesis of implant-related infec-
tions, with special attention to the alarming phenomenon of
antibiotic resistance [129]. Future investigations should also
focus on designing animal model systems to study in vivo-
grown biofilms and infections.
The potential applications of nanotechnology for diag-
nosis, prevention, and treatment of diseases are currently
very broad [129–132]. Nanostructured materials have been
repeatedly shown to be able of improving biomaterial-cells
interactions (e.g., osteointegration of bone implants or seed-
ing of endothelial cells on vascular scaffolds) in comparison
with the materials of the past [132–135]. Moreover, they
appear endowed with the potential to contrast biomaterials
infectability. Besides creativity and visionary power, practical
application of nanomedicine requires simple approaches and
systematic development. In this review, we have provided
an overview on some fascinating developments in the area
of nanomedical research and applications. Since the field is
currently expanding at a very fast pace, we could not describe
all aspects of current nanomedicine in detail. Our aim was
mainly to give a view of developments and research topics
in chemistry, biology, physics, and engineering that have the
potential to revolutionize clinical therapies and diagnostics.
Surface engineering based on nanostructured materials
offers a series of favorable features to contrast bacterial adhe-
sion and biofilm growth. It also represents a valid alternative
to classic antibiotic therapies or to antimicrobial-coated
or -loaded biomaterials. Surface engineering, by acting on
the nanotopology, reduces the area available for bacterial
attachment or generates superhydrophobic surfaces. Nanos-
tructured surfaces have been shown to be capable of altering
the 3D conformation of adsorbed proteins and this could
potentially have an effect also on host adhesins filming the
biomaterial surfaces, thwarting the MSCRAMM-dependent
bacterial adhesion. Many approaches of surfaces engineer-
ing are being proposed, all aimed at contrasting bacterial
adhesion, each exhibiting some antiadhesive feature [7]. The
identification of the most effective anti-infective solutions
will require evidence-based data, obtained from multicenter
clinical trials, together with appropriately designed and well-
structured international registers. In the absence of these
evidence-based data, even if myriads of new technologies
will be introduced, the evaluation of antiadhesive nanoengi-
neered biomaterial surfaces could run anyway the risk of
remaining an uncertain matter as it is not robustly supported
by reliable data [7].
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